PA8781201A1 - "proceso mejorado par la elaboración de hidrazidas" - Google Patents
"proceso mejorado par la elaboración de hidrazidas"Info
- Publication number
- PA8781201A1 PA8781201A1 PA20088781201A PA8781201A PA8781201A1 PA 8781201 A1 PA8781201 A1 PA 8781201A1 PA 20088781201 A PA20088781201 A PA 20088781201A PA 8781201 A PA8781201 A PA 8781201A PA 8781201 A1 PA8781201 A1 PA 8781201A1
- Authority
- PA
- Panama
- Prior art keywords
- hydrazids
- elaboration
- acil
- suspension
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/04—Preparation of hydrazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coating Apparatus (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
SE DESCRIBE UN MÉTODO PARA PREPARAR HIDRAZIDAS A PARTIR DE HIDRAZINA Y UN CLORURO DE ACILO QUE COMPRENDE LAS ETAPAS DE (A) PREPARAR UNA SUSPENSIÓN SUSTANCIALMENTE AGITADA Y UN DISOLVENTE INERTE A BAJA TEMPERATURA ; Y (B) AGREGAR UN CLORURO DE ACILO CONTINUAMENTE A DICHA SUSPENSIÓN. EL MÉTODO EVITA O LIMITA LA PRODUCCIÓN DE SUBPRODUCTOS BIS HIDRAZIDA NO DESEADOS. EL MÉTODO SE UTILIZA PARA PREPARAR HIDRAZIDA DE ÁCIDO 3-METIL-3-MERCAPTOBUTANOICO, UNA MOLÉCULA UTILIZADA PARA ENLAZAR CALICHEAMICINA A UN ANTICUERPO MONOCLONAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93952907P | 2007-05-22 | 2007-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8781201A1 true PA8781201A1 (es) | 2008-12-18 |
Family
ID=39810161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20088781201A PA8781201A1 (es) | 2007-05-22 | 2008-05-22 | "proceso mejorado par la elaboración de hidrazidas" |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8110705B2 (es) |
| EP (2) | EP2465541B1 (es) |
| JP (4) | JP5697446B2 (es) |
| KR (1) | KR101547705B1 (es) |
| CN (2) | CN101835494B (es) |
| AR (1) | AR066674A1 (es) |
| AU (1) | AU2008256905B2 (es) |
| BR (1) | BRPI0811140B1 (es) |
| CA (1) | CA2687852A1 (es) |
| CL (1) | CL2008001490A1 (es) |
| CY (2) | CY1119373T1 (es) |
| DK (2) | DK2465541T3 (es) |
| ES (2) | ES2642888T3 (es) |
| HK (2) | HK1147736A1 (es) |
| HU (2) | HUE036704T2 (es) |
| IL (1) | IL202242A (es) |
| MX (1) | MX2009012587A (es) |
| PA (1) | PA8781201A1 (es) |
| PE (1) | PE20090305A1 (es) |
| PL (2) | PL2155258T3 (es) |
| PT (2) | PT2155258T (es) |
| SI (2) | SI2155258T1 (es) |
| TW (1) | TW200904784A (es) |
| WO (1) | WO2008147765A1 (es) |
| ZA (1) | ZA200908229B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2465541T3 (en) * | 2007-05-22 | 2018-09-17 | Wyeth Llc | improved methods for producing hydrazides |
| EP3065780A1 (en) | 2013-11-04 | 2016-09-14 | Pfizer Inc. | Anti-efna4 antibody-drug conjugates |
| AU2014343268B2 (en) * | 2013-11-04 | 2018-11-15 | Pfizer Inc. | Intermediates and methods for synthesizing calicheamicin derivatives |
| WO2015168019A2 (en) | 2014-04-30 | 2015-11-05 | Pfizer Inc. | Anti-ptk7 antibody-drug conjugates |
| WO2016105330A1 (en) * | 2014-12-22 | 2016-06-30 | Hewlett Packard Enterprise Development Lp | Response to an inoperative network device managed by a controller |
| WO2019018647A1 (en) | 2017-07-20 | 2019-01-24 | Pfizer Inc. | ANTI-GD3 ANTIBODIES AND CONJUGATES ANTIBODY-MEDICATION |
| US20200318053A1 (en) | 2017-10-03 | 2020-10-08 | University Public Corporation Osaka | Cell culture container, method for acquiring cells, and method for culturing cells |
| CN109574870A (zh) * | 2018-12-25 | 2019-04-05 | 维思普新材料（苏州）有限公司 | 一种酰肼的连续制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US623230A (en) * | 1899-04-18 | Rotary ore-cooler | ||
| US4291022A (en) | 1975-03-11 | 1981-09-22 | Sandoz Ltd. | Organic compounds |
| DE2608336A1 (de) | 1975-03-11 | 1976-09-30 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4479953A (en) | 1983-08-25 | 1984-10-30 | Merck & Co., Inc. | Pyrazine aldimine compounds as antimicrobial agents |
| US4970198A (en) | 1985-10-17 | 1990-11-13 | American Cyanamid Company | Antitumor antibiotics (LL-E33288 complex) |
| US4729781A (en) | 1986-08-04 | 1988-03-08 | Sandoz Ltd. | 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents |
| ES2023217B3 (es) * | 1986-08-04 | 1992-01-01 | Sandoz Ag | Derivados de acido benzohidroxamico. |
| US4939244A (en) | 1987-01-30 | 1990-07-03 | American Cyanamid Company | Pseudoaglycones of LL-E33288 antibiotics |
| US5079233A (en) | 1987-01-30 | 1992-01-07 | American Cyanamid Company | N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| US5770701A (en) | 1987-10-30 | 1998-06-23 | American Cyanamid Company | Process for preparing targeted forms of methyltrithio antitumor agents |
| US5053394A (en) * | 1988-09-21 | 1991-10-01 | American Cyanamid Company | Targeted forms of methyltrithio antitumor agents |
| JPH05222044A (ja) * | 1991-10-25 | 1993-08-31 | Eastman Kodak Co | ２当量ピラゾロトリアゾールマゼンタカプラーの製造 |
| DK0641316T3 (da) * | 1991-11-22 | 1997-08-11 | Uniroyal Chem Co Inc | Insekticide phenylhydrazinderivater. |
| US5690904A (en) * | 1993-07-12 | 1997-11-25 | Amersham International Plc | Diagnostic radiopharmaceutical compounds (That) |
| US5443953A (en) * | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
| US5403015A (en) * | 1993-12-09 | 1995-04-04 | Forte; Steven L. | Cards and methods for playing casino 21 or blackjack |
| AU3264695A (en) | 1994-08-23 | 1996-03-14 | Nissan Chemical Industries Ltd. | Pyridine derivative |
| IT1292092B1 (it) | 1997-06-05 | 1999-01-25 | Geange Ltd | Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali |
| AU760688B2 (en) | 1998-10-16 | 2003-05-22 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for GABA receptors |
| GB0008696D0 (en) | 2000-04-07 | 2000-05-31 | Merck Sharp & Dohme | Therapeutic agents |
| CN1638776A (zh) * | 2001-06-08 | 2005-07-13 | 西托维亚公司 | 取代的3－芳基－5－芳基－[1,2,4]－噁二唑和类似物 |
| DK1507556T3 (en) * | 2002-05-02 | 2016-09-12 | Wyeth Holdings Llc | Calicheamicin derivative-carrier conjugates |
| US6803379B2 (en) | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| US7144876B2 (en) | 2002-12-18 | 2006-12-05 | Cytovia, Inc. | 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| CA2509413C (en) | 2002-12-20 | 2012-05-01 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
| US7304161B2 (en) | 2003-02-10 | 2007-12-04 | Intrexon Corporation | Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| WO2004101512A2 (en) * | 2003-05-13 | 2004-11-25 | Smithkline Beecham Corporation | Naphthyridine integrase inhibitors |
| BRPI0412040A (pt) | 2003-07-02 | 2006-09-05 | Sugen Inc | hidrazidas de indolinona como inibidores de c-met |
| TW200519094A (en) | 2003-07-02 | 2005-06-16 | Vertex Pharma | Pyrimidines useful as modulators of voltage-gated ion channels |
| SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| US20070203098A1 (en) * | 2004-04-06 | 2007-08-30 | Semafore Pharmaceuticals, Inc. | Pten Inhibitors |
| SV2006002258A (es) * | 2004-10-08 | 2006-09-19 | Wyeth Corp | Inmunoterapia de trastornos autoinmunes |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| DK2465541T3 (en) * | 2007-05-22 | 2018-09-17 | Wyeth Llc | improved methods for producing hydrazides |
-
2008
- 2008-05-20 DK DK12159159.8T patent/DK2465541T3/en active
- 2008-05-20 ES ES08755945.6T patent/ES2642888T3/es active Active
- 2008-05-20 PL PL08755945T patent/PL2155258T3/pl unknown
- 2008-05-20 HU HUE08755945A patent/HUE036704T2/hu unknown
- 2008-05-20 PL PL12159159T patent/PL2465541T3/pl unknown
- 2008-05-20 KR KR1020097026806A patent/KR101547705B1/ko active Protection Beyond IP Right Term
- 2008-05-20 EP EP12159159.8A patent/EP2465541B1/en active Active
- 2008-05-20 AU AU2008256905A patent/AU2008256905B2/en active Active
- 2008-05-20 CA CA2687852A patent/CA2687852A1/en not_active Abandoned
- 2008-05-20 JP JP2010509499A patent/JP5697446B2/ja active Active
- 2008-05-20 WO PCT/US2008/064213 patent/WO2008147765A1/en active Application Filing
- 2008-05-20 SI SI200831859T patent/SI2155258T1/sl unknown
- 2008-05-20 CN CN2008800216526A patent/CN101835494B/zh active Active
- 2008-05-20 PT PT87559456T patent/PT2155258T/pt unknown
- 2008-05-20 MX MX2009012587A patent/MX2009012587A/es active IP Right Grant
- 2008-05-20 DK DK08755945.6T patent/DK2155258T3/en active
- 2008-05-20 ES ES12159159.8T patent/ES2686019T3/es active Active
- 2008-05-20 SI SI200831994T patent/SI2465541T1/sl unknown
- 2008-05-20 CN CN201110434577.XA patent/CN102558001B/zh active Active
- 2008-05-20 HU HUE12159159A patent/HUE039657T2/hu unknown
- 2008-05-20 PE PE2008000869A patent/PE20090305A1/es not_active Application Discontinuation
- 2008-05-20 EP EP08755945.6A patent/EP2155258B1/en active Active
- 2008-05-20 BR BRPI0811140-5A patent/BRPI0811140B1/pt active IP Right Grant
- 2008-05-20 PT PT12159159T patent/PT2465541T/pt unknown
- 2008-05-20 US US12/123,777 patent/US8110705B2/en active Active
- 2008-05-22 PA PA20088781201A patent/PA8781201A1/es unknown
- 2008-05-22 TW TW097118930A patent/TW200904784A/zh unknown
- 2008-05-22 CL CL200801490A patent/CL2008001490A1/es unknown
- 2008-05-22 AR ARP080102165A patent/AR066674A1/es unknown
-
2009
- 2009-11-19 IL IL202242A patent/IL202242A/en active IP Right Grant
- 2009-11-20 ZA ZA200908229A patent/ZA200908229B/xx unknown
-
2011
- 2011-02-23 HK HK11101744.4A patent/HK1147736A1/xx unknown
-
2012
- 2012-01-27 US US13/360,220 patent/US8383857B2/en active Active
- 2012-12-11 HK HK12112795.8A patent/HK1172008A1/zh unknown
-
2013
- 2013-01-31 US US13/755,886 patent/US8853451B2/en active Active
- 2013-08-23 JP JP2013172956A patent/JP2013234203A/ja not_active Withdrawn
-
2014
- 2014-10-02 US US14/504,738 patent/US9227924B2/en active Active
-
2015
- 2015-11-06 JP JP2015218118A patent/JP2016026219A/ja not_active Withdrawn
- 2015-12-18 US US14/973,869 patent/US9738602B2/en active Active
-
2017
- 2017-08-03 JP JP2017150482A patent/JP2017193584A/ja active Pending
- 2017-09-20 CY CY20171100991T patent/CY1119373T1/el unknown
-
2018
- 2018-08-13 CY CY181100854T patent/CY1120592T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8781201A1 (es) | "proceso mejorado par la elaboración de hidrazidas" | |
| BR112014000688B8 (pt) | Composições pesticidas, e processo para controle de pestes | |
| EA200801697A1 (ru) | Способ выделения органического амина | |
| UY30662A1 (es) | Método de cristalizacion discontinuo para cristalizar un anticuerpo anti-htnfalfa, cristales de anticuerpo obtenido por dicho método, composiciones que los conitenen y aplicaciones | |
| BRPI0705417A (pt) | produto alimentìcio aerado e processos para a produção de um produto alimentìcio aerado | |
| BRPI0518758A2 (pt) | compostos de acetamida como fungicidas | |
| ATE541928T1 (de) | Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen | |
| CY1109568T1 (el) | Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων | |
| GT200600213A (es) | Metodos para sintetizar 3-cianoquinolinas sustituidas y sus intermediarios | |
| BR112012025578A2 (pt) | extensibilidade de pesquisa para aplicações de terceiros | |
| EA200901175A1 (ru) | Способ получения 2,6-дихлор-4-(трифторметил)фенилгидразина, используя смеси дихлор-фтор-трифторметилбензолов | |
| Liu et al. | Dimeric trigger factor stably binds folding-competent intermediates and cooperates with the DnaK-DnaJ-GrpE chaperone system to allow refolding | |
| DK1907519T3 (da) | Anvendelse af fulleren C60 som stabilisator for phosphoglyceridholdige olier | |
| PL417788A1 (pl) | 8-O-β-D-4"-metoksyglukopiranozylo-6-metyloflawon i sposób wytwarzania 8-O-β-D-4"-metoksyglukopiranozylo-6-metyloflawonu | |
| Mohamed et al. | SARS-CoV 3C-like protease inhibitors of some newly synthesized substituted pyrazoles and substituted pyrimidines based on 1-(3-aminophenyl)-3-(1Hindol-3-yl) prop-2-en-1-one | |
| PL417789A1 (pl) | Sposób wytwarzania 7-O-ß-D-4"-metoksyglukopiranozyloflawanonu | |
| PL432958A1 (pl) | 2-Fenylo-6-metylo-4-O-β-D-(4''-O-metyloglukopiranozylo)-chroman i sposób wytwarzania 2-fenylo-6-metylo-4-O-β-D-(4''-O-metyloglukopiranozylo)-chromanu | |
| AR068968A1 (es) | Procedimiento para preparar fenilhidracinas sustituidas | |
| PL424952A1 (pl) | Sposób wytwarzania 3-O-β-D-glukopiranozylo-3',4',5,7-tetrahydroksyflawonu | |
| PL424951A1 (pl) | 3-O-β-D-(4''-O-metyloglukopiranozylo)-3',4',5,7-tetrahydroksyflawon i sposób wytwarzania 3-O-β-D-(4''-O-metyloglukopiranozylo)-3',4',5,7-tetrahydroksyflawonu | |
| PL416996A1 (pl) | 7-O-ß-D-4'' -metoksyglukopiranozylo-4'-hydroksyizoflawon oraz sposób wytwarzania 7-O-ß-D-4''-metoksyglukopiranozylo-4'-hydroksyizoflawonu | |
| PL421049A1 (pl) | 3-O-β-D-(4''-O-metyloglukopiranozylo)-flawon i sposób wytwarzania 3-O-β-D-(4''-O-metyloglukopiranozylo)-flawonu | |
| Grand | Linking Moralisation and Class Identity: The Role of Ressentiment and Respectability in the Social Reaction to ‘ Chavs’ | |
| PL417787A1 (pl) | 8-O-ß-D-4"-metoksyglukopiranozylo-6-metyloflawon i sposób wytwarzania 8-O-ß-D-4"-metoksyglukopiranozylo-6-metyloflawonu | |
| Stanevičienė et al. | The Effects of aluminium and selenite ions on redox status in mice tissues |